GlassScriptPhysician profile
Jay D Schlaifer
NPI 1841251592
$11,193.64
in general payments reported to CMS, 2019-2025
15 companies · $883 in 2025
The $883 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,169 · 2020: $4,129 · 2021: $14.81 · 2022: $331 · 2023: $954 · 2024: $712 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,549.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Research Incorporated | $7,975.00 | 2019-2020 | |
| Medtronic, INC. | $554.44 | 2021-2025 | Onyx Frontier, Ffrangio, Symplicity G3 |
| Biotronik INC. | $468.93 | 2022-2024 | Orsiro Mission, Pk Papyrus, Recross |
| Shockwave Medical, INC | $415.64 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $406.56 | 2023-2025 | Synergy, Watchman Access System, Avvigo Guidance System |
| Abbott Laboratories | $339.30 | 2024-2025 | Dragonfly Opstar, Confirm Rx, Merlin@Home |
| Edwards Lifesciences Corporation | $210.90 | 2022-2023 | Sapien 3 Ultra Resilia |
| Asahi Intecc USA, INC. | $199.61 | 2025 | Asahi Coronary Wires |
| Medtronic Vascular, INC. | $178.57 | 2019-2020 | |
| Teleflex LLC | $165.45 | 2023 | Guideliner |
| Abiomed | $134.43 | 2023 | Impella |
| Janssen Pharmaceuticals, INC | $82.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.20 | 2019 | |
| Gilead Sciences, INC. | $14.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Schlaifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.